Background Image
Table of Contents Table of Contents
Previous Page  76 / 78 Next Page
Information
Show Menu
Previous Page 76 / 78 Next Page
Page Background

NCCN Guidelines for Patients

®

Soft Tissue Sarcoma, Version 1.2014

74

Index

2

nd

opinion

63

ablation

8–9, 24–27, 46

amputation

22–23

brachytherapy

9

biopsy

14, 16, 30, 32, 34, 38–41, 50, 52

cancer grade

16–17, 32, 40, 52

cancer stage

17–24, 59

chemotherapy

9–11, 16, 20–27, 32, 34, 36, 53

chemoembolization

9, 46

chemoradiation

10, 20–23

clinical trials

12, 21, 23–24, 36, 47

computed tomography

9, 14–16, 31, 32, 38, 40–42,

44–45, 47, 51

embolization

8–9, 24–27, 46

external beam radiation therapy

8–9, 23

immunotherapy

10–11

interoperative radiation therapy

8–9, 34

isolated limb chemotherapy

22–23

magnetic resonance imaging

14–17, 31, 38, 40, 47, 51

medical history

14–15, 18–19, 22–25, 30–31, 38–39,

44–45, 50–51, 54

multidisciplinary team

14–15, 30–31, 38–39, 50–51

mutation

17, 33, 40, 41

NCCN Member Institutions

73

NCCN Panel Members

72

observation

22–27, 36, 44, 53–54

palliative care

23, 25, 27, 36

physical exam

14–15, 18–19, 22–25, 30–31, 34–35,

38–39, 44–45, 50–51, 54

positron emission tomography

14, 16, 38, 41, 45, 47

radiation therapy

8–9, 18–27, 32, 34–36, 46, 54–55

recurrence

26–27, 34, 44

rehabilitation

18–19, 22–24, 55

shared decision–making

58

stereotactic body radiation therapy

9, 24–27

supportive care

8, 22–23, 25–27, 36, 46–47

surgery

8–9, 16, 18, 20–27, 30, 32, 34–36, 38–42, 44–46,

52–55

syndrome

15, 17, 31, 33, 41, 51

targeted therapy

10-11

Index